Aktuelle Neurologie 2001; 28(8): 373-382
DOI: 10.1055/s-2001-17539
ÜBERSICHT
Übersicht
© Georg Thieme Verlag Stuttgart · New York

Seltene bakterielle Infektionen des Nervensystems

Rare Bacterial Infections of the Nervous SystemE. Schmutzhard1 , W.  H. Pfister2
  • 1Univ.-Klinik für Neurologie, Innsbruck (Vorstand: Univ.-Prof. Dr. W. Poewe)
  • 2Univ.-Klinik für Neurologie, Klinikum Großhadern, München (Vorstand: Univ.-Prof. Dr. Th. Brandt)
Further Information

Publication History

Publication Date:
28 September 2001 (online)

Zusammenfassung

In dieser Übersicht werden antimikrobiell behandelbare bakterielle Erkrankungen des Nervensystems dargestellt, die in ihrer lnzidenz und Prävalenz selten bis sehr selten in neurologischen Abteilungen Mitteleuropas gesehen werden, die aber bei rechtzeitiger Diagnose doch in vielen Fällen ausreichend gut und endgültig behandelbar sind. Die Darstellung dieser sieben verschiedenen bakteriellen ZNS-Infektionserkrankungen soll dazu beitragen, das Bewusstsein über diese seltenen Infektionserreger zu schärfen und den „level of suspicion” zu erhöhen. Die ausführliche Darstellung der diagnostischen Schritte, der neurologischen Symptomatik und vor allem der wesentlichen epidemiologischen Parameter sowie der modernen akzeptierten antimikrobiellen Chemotherapie soll dazu beitragen, dass Erkrankungen mit diesen Erregern rechtzeitig diagnostiziert und appropriat chemotherapiert werden. Letztlich soll diese Übersicht vor allem differenzialdiagnostische Überlegungen erleichtern.

Rare Bacterial Infections of the Nervous System

In this review bacterial diseases of the nervous system treatable by antimicrobial chemotherapy are described, in particular, the incidence and prevalence of neurologic infectious diseases which are seen rarely or very rarely in Central European Hospitals and which benefit clearly from timely diagnosis and appropriate therapy. Seven bacterial pathogens, i.e. Rickettsia spp., Ehrlichia spp., Bartonella spp., Brucella spp., Mycoplasma pneumoniae, Chlamydia spp., Tropheryma Whippelii, are described and their description should enhance the level of suspicion in case of diagnostically unclear neurologic infection. The diagnostic steps, signs and symptoms, and in particular, the pertinent epidemiologic parameters as weIl as the most modern antimicrobial chemotherapeutic recommendations support the notion that these diseases benefit from early diagnosis and appropriate therapy. Differential diagnostic considerations are listed in each chapter.

Literatur

  • 1 Schmutzhard E. Entzündliche Erkrankungen des Nervensystems. Stuttgart; Georg Thieme Verlag 2000
  • 2 Kim J H, Durack D T. Rickettsiae. In: Scheld WM, Whitley RJ, Durack DT lnfections of the Central Nervous System. Philadelphia; Lippincott-Raven 1997 2nd ed: 403-416
  • 3 Rydkina E, Roux V, Rudakov N. et al . New rickettsiae in ticks collected in territories of the former Soviet Union.  Emerg lnfect Dis. 1999;  5 811-814
  • 4 Raoult D, Roux V. The body louse as a vector of reemerging human disease.  Clin lnfect Dis. 1999;  29 888-911
  • 5 Fingerle V, Goodman J L, Johnson R C. et al . Epidemiologic aspects of human granulocytic ehrlichiosis in Southern Germany.  Wien Klin Wochenschr. 1999;  111 1000-1004
  • 6 Walker D H, Dumler J S. Emergence of the ehrlichioses as human health problems.  Emerg lnfect Dis. 1996;  2 18-19
  • 7 Childs J E, Ellis B A, Nicholson W L. et al . Shared vector-borne zoonoses of the Old World and New World: home grown or translocated?.  Schweiz Med Wochenschr. 1999;  129 1099-1105
  • 8 Dehio C, Sander A. Bartonella as emerging pathogens.  Trends Microbiol. 1999;  7 226-228
  • 9 Haimerl M, Tenter A M, Simon K. et al . Seroprevalence of Bartonella henselae in cats in Germany.  J Med Microbiol. 1999;  48 849-856
  • 10 Adal K A, Cockerell C J, Petri W A. Cat-scratch-disease, bacillar angiomatosis and other infections due to Rochalimaea.  New Engl J Med. 1994;  330 1509-1515
  • 11 Noyola D E, Holder D L, Fishman M A, Edwards M S. Recurrent encephalopathy in cat-scratch disease.  Pediatr lnfect Dis J. 1999;  18 567-568
  • 12 Landau Z, Green L. Chronic brucellosis in workers in a meat-packing plant.  Scand J lnfect Dis. 1999;  31 511-512
  • 13 Mishal J, Ben-lsrael N, Levin Y. et al . Brucellosis outbreak: analysis of risk factors and serologic screening.  Int J Mol Med. 1999;  4 655-658
  • 14 AI Deeb S M, Yaqub B A, Sharif H S, Phadke J G. Neurobrucellosis: clinical characteristics, diagnosis, and outcome.  Neurology. 1989;  39 498-501
  • 15 Solera J, Lozano E, Martinez-Alfaro E, Espinosa A. Brucellar Spondylitis: Review of 35 Cases and Literature Survey.  Clin lnfect Dis. 1999;  29 1440-1449
  • 16 Yagupsky P. Detection of Brucellae in blood cultures.  J Clin Microbiol. 1999;  37 3437-3442
  • 17 Young E J. Utility of the enzyme-linked immunosorbent assay for diagnosing neurobrucellosis.  Clin lnfect Dis. 1998;  26 1481
  • 18 Da Cunha S. Adenosine deaminase in cerebrospinal fluid during brucella meningitis.  J lnfect. 1995;  31 82-83
  • 19 Aduljabbar M S. Adenosine deaminase concentration in cerebrospinal fluid during brucella meningitis.  J lnfect. 1994;  29 41-44
  • 20 Cisneros J M, Viciana P, Colmenero J. et al . Multicenter prospective study of treatment of Brucella melitensis brucellosis with doxycycline for 6 weeks plus streptomycin for 2 weeks.  Antimicrob Agents Chemother. 1990;  34 881-883
  • 21 Koskiniemi M. CNS manifestations associated with Mycoplasma pneumoniae infections: summary of cases at the University of Helsinki and review.  Clin lnfect Dis. 1993;  17 52-57
  • 22 Brandel J P, Vidailhet M, Noseda G. et al . Mycoplasma pneumoniae postinfectious encephalomyelitis with bilateral striatal necrosis.  Mov Disord. 1996;  11 333-336
  • 23 Ambramovitz P, Schvartzman P, Harel D. et al . Direct invasion of the central nervous system by Mycoplasma pneumoniae: a report of two cases.  J lnfect Dis. 1987;  155 482-487
  • 24 Wohlman A, Gallily R, Yirmiya R, Weidenfeld J. Characterization of the effect of Mycoplasma fermentans on the hypothalamo-pituitary-adrenal axis.  Neuroendocrinology. 1997;  66 221-222
  • 25 Narita N, ltakura O, Matsuzono Y, Togashi T. Analysis of mycoplasma central nervous system involvement by polymerase chain reaction.  Pediatr lnfec J. 1995;  14 236-237
  • 26 Cizman M, Jazbec J. Etiology of acute encephalitis in childhood in Slovenia.  Pediatr lnfect Dis J. 1993;  12 903-908
  • 27 Humbert P. Meningo-encephalitis caused by Chlamydia trachomatis.  Presse Med. 1990;  19 1243
  • 28 Socan M, Beovic B, Kese D. Chlamydia pneumoniae and meningoencephalitis.  N Engl J Med. 1994;  11 331-406
  • 29 Raoult D, Birg M l, La Scola B. et al . Cultivation of the bacillus of Whipple's disease.  N Engl J Med. 2000;  342 620-625
  • 30 Mendel E, Khoo L T, Go J L. et al . lntracerebral Whipple's disease diagnosed by stereotactic biopsy: a case report and review of the literature.  Neurosurg. 1999;  44 203-209
  • 31 Anderson M. Neurology of Whipple's disease.  J Neurol Neurosurg Psychiatry. 2000;  68 2-5
  • 32 Helliwell T R, Appleton R E, Mapstone N C. et al . Dermatomyositis and Whipple's disease.  Neuromuscul Disord. 2000;  10 46-51
  • 33 Suzer J, Demirkam N, Tahta K. et al . Whipple's disease confined to the central nervous system: case report and review of the literature.  Scand lnfec Dis. 1999;  31 411-414
  • 34 De Coene B, Gilliard C, lndekeu P. et al . Whipple's disease confined to the central nervous system.  Neuroradiol. 1996;  38 325-327
  • 35 Singer R. Diagnosis and treatment of Whipple's disease.  Drugs. 1998;  55 699-704

Univ.-Prof. Dr. Erich Schmutzhard

Univ.-Klinik für Neurologie
Neurologische lntensivstation

Anichstraße 35

6020 Innsbruck
Österreich

Email: erich.schmutzhard@uibk.ac.at

    >